MSH6 and endometrial cancer: In the future, it is necessary to collect clinical samples of endometrial cancer or construct mouse models to explore the relationship between different MMR genes, especially MSH6, and immune infiltration and ICIs response by using sc-RNA-seq or distinguish the cellular and molecular characteristics of different MMR deficiency patterns to find the cause for primary or secondary resistance of dMMR EC to ICIs treatment.